The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal complies with the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).
Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or published in an electronic or printed medium. The journal should be informed of manuscripts that have been submitted to another journal for evaluation and rejected for publication. The submission of previous reviewer reports will expedite the evaluation process. Manuscripts that have been presented in a meeting should be submitted with detailed information of the event, including the name of the organization, the date, and the location.
The Erciyes Medical Journal does not accept multiple submissions or duplicate submissions of articles published in a different language. Nevertheless, the articles will not be processed that are sending again by different new ID numbers which has been already rejected or that are still under processing (revised etc.).
Manuscripts submitted to Erciyes Medical Journal will undergo a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in their field in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation process of manuscripts submitted by editors or by the editorial board members of the journal. The editor-in-chief is the final authority in the decision-making process for all submissions.
Reviews are typically completed within one month of submission to the journal. Authors will be sent constructive reviewer comments intended to be useful. In general, the instructions, objections, and requests made by the reviewers should be followed. The revised manuscript should clearly and precisely indicate every step taken in accordance with the reviewers' notes. A list of responses and the corrections made to each comment should be provided.
Studies using human or animal subjects should be approved by the appropriate institutional and local Ministry of Health ethics committees. Ethics approval of research protocols in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects,” amended in October 2013, www.wma.net) is required for experimental, clinical, and drug studies, as well as for some case reports. Ethics committee reports or an equivalent official document may be requested from the authors. For manuscripts involving experimental research on humans, a statement should be included that shows that written, informed consent of patients and volunteers was obtained. For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly. A statement regarding patient consent, and the name of the ethics committee, the ethics committee approval date, and number should be stated in the Materials and Methods section of the manuscript. It is the authors’ responsibility to carefully protect patients’ anonymity. For photographs that may reveal the identity of the patients, signed releases of the patient or of their legal representative should be enclosed.
Each individual listed as an author should fulfill the authorship criteria recommended by the International Committee of Medical Journal Editors (ICMJE - www.icmje.org). The ICMJE recommends that authorship be based on the following 4 criteria:
In addition to being accountable for their own work, authors should have confidence in the integrity of the contributions of their co-authors and each author should be able to identify which co-authors are responsible for other parts of the work.
All of those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged on the title page of the manuscript.
The Erciyes Medical Journal requires that corresponding authors submit a signed and scanned version of the authorship contribution form (available for download through https://www.erciyesmedj.com/) during the initial submission process in order to appropriately indicate and observe authorship rights and to prevent ghost or honorary authorship. If the editorial board suspects a case of “gift authorship,” the submission will be rejected without further review. As part of the submission of the manuscript, the corresponding author should also send a short statement declaring that they accept all responsibility for authorship during the submission and review stages of the manuscript.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
The Open Researcher and Contributor ID (ORCID) number of each author must be submitted when creating an account for correspondence. To obtain an ORCID number, please visit https://orcid.org/
DISCLOSURE AND CONFLICTS OF INTEREST
The Erciyes Medical Journal requires the authors and the individuals involved in the evaluation process of submitted manuscripts to disclose any existing or potential conflicts of interests, including financial, consultant, and institutional relationships, that might lead to potential bias or a conflict of interest. Any financial grants or other support received for a submitted study from individuals or institutions should be disclosed to the editorial board. The ICMJE Potential Conflict of Interest Disclosure Form should be completed and submitted by all contributing authors to disclose any potential conflict of interest. Cases of a potential conflict of interest of the editors, authors, or reviewers are resolved by the journal’s editorial board according to COPE and ICMJE guidelines.
The editorial board of the journal handles all appeal and complaint cases based on COPE guidelines. In such cases, authors should contact the editorial office. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The journal editor-in-chief is the final authority in the decision-making process for all appeals and complaints.
When submitting a manuscript to the Erciyes Medical Journal, authors agree to assign the copyright of the manuscript to the Erciyes University School of Medicine. If rejected for publication, the copyright of the manuscript will be reassigned to the authors. The Erciyes Medical Journal requires each submission to be accompanied by a Copyright Transfer Form (available for download at https://www.erciyesmedj.com/). When using previously published content, including figures, tables, or any other material in either print or electronic format, the authors must obtain permission from the copyright holder. Legal, financial, and criminal liabilities in this regard belong to the author(s).
Statements or opinions expressed in the manuscripts published in the Erciyes Medical Journal reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility for the published content rests with the authors.
All submissions are screened using similarity detection software (iThenticate; Turnitin LLC, Oakland, CA, USA) at least two times: on submission and after completing revisions. In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, or data falsification/fabrication, the editorial board will follow and act in accordance with COPE guidelines. Plagiarism, including self-plagiarism, that is detected at any stage will result in rejection of the manuscript.
OPEN ACCESS AND CREATIVE COMMONS USER LICENSE
The Erciyes Medical Journal is an open access journal, which means that all content is freely available without charge to any user. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or to use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
Creative Commons User License
This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License (CC BY-NC 4.0).
This journal assesses no submission fees, publication fees, or page charges.